These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 31420886)

  • 1. Nonimmune hydrops fetalis and congenital disorders of glycosylation: A systematic literature review.
    Makhamreh MM; Cottingham N; Ferreira CR; Berger S; Al-Kouatly HB
    J Inherit Metab Dis; 2020 Mar; 43(2):223-233. PubMed ID: 31420886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should PMM2-deficiency (CDG Ia) be searched in every case of unexplained hydrops fetalis?
    Léticée N; Bessières-Grattagliano B; Dupré T; Vuillaumier-Barrot S; de Lonlay P; Razavi F; El Khartoufi N; Ville Y; Vekemans M; Bouvier R; Seta N; Attié-Bitach T
    Mol Genet Metab; 2010; 101(2-3):253-7. PubMed ID: 20638314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital Disorder of Glycosylation (CDG) Presenting as Non-immune Hydrops Fetalis.
    Panigrahy N; Lingappa L; Ramadevi AR; Venkatlakshmi A
    Indian J Pediatr; 2016 Apr; 83(4):359-60. PubMed ID: 26365158
    [No Abstract]   [Full Text] [Related]  

  • 4. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops.
    Edwards M; McKenzie F; O'callaghan S; Somerset D; Woodford P; Spilsbury J; Fietz M; Fletcher J
    Prenat Diagn; 2006 Oct; 26(10):985-8. PubMed ID: 16915591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital disorder of glycosylation type Ia presenting with hydrops fetalis.
    van de Kamp JM; Lefeber DJ; Ruijter GJ; Steggerda SJ; den Hollander NS; Willems SM; Matthijs G; Poorthuis BJ; Wevers RA
    J Med Genet; 2007 Apr; 44(4):277-80. PubMed ID: 17158594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonimmune hydrops fetalis in a children's hospital: a six-year series.
    Ng ZM; Seet MJ; Erng MN; Buendia F; Chang AS; Sriram B
    Singapore Med J; 2013 Sep; 54(9):487-90. PubMed ID: 24068055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.
    Mone F; Eberhardt RY; Hurles ME; Mcmullan DJ; Maher ER; Lord J; Chitty LS; Dempsey E; Homfray T; Giordano JL; Wapner RJ; Sun L; Sparks TN; Norton ME; Kilby MD
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):509-518. PubMed ID: 33847422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Immune Hydrops Fetalis: Do Placentomegaly and Polyhydramnios Matter?
    Berger VK; Sparks TN; Jelin AC; Derderian C; Jeanty C; Gosnell K; Mackenzie T; Gonzalez JM
    J Ultrasound Med; 2018 May; 37(5):1185-1191. PubMed ID: 29076544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonimmune Hydrops Fetalis.
    Dunn SB; Whittington JR
    Neoreviews; 2024 Aug; 25(8):e475-e485. PubMed ID: 39085173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Exome Sequencing versus Targeted Gene Panels for Prenatal Diagnosis of Fetal Effusions and Non-Immune Hydrops Fetalis.
    Avram CM; Caughey AB; Norton ME; Sparks TN
    Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100724. PubMed ID: 35995366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonimmune hydrops fetalis part I: etiology and pathophysiology.
    Randenberg AL
    Neonatal Netw; 2010; 29(5):281-95. PubMed ID: 20829175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal storage disorders as an etiology of nonimmune hydrops fetalis: A systematic review.
    Iyer NS; Gimovsky AC; Ferreira CR; Critchlow E; Al-Kouatly HB
    Clin Genet; 2021 Nov; 100(5):493-503. PubMed ID: 34057202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of monogenic etiologies of nonimmune hydrops fetalis.
    Quinn AM; Valcarcel BN; Makhamreh MM; Al-Kouatly HB; Berger SI
    Genet Med; 2021 Jan; 23(1):3-12. PubMed ID: 33082562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A previously undescribed form of congenital disorder of glycosylation with variable presentation in siblings: early fetal loss with hydrops fetalis, and infant death with hypoproteinemia.
    McKenzie FA; Fietz M; Fletcher J; Smith RL; Wright IM; Jaeken J
    Am J Med Genet A; 2007 Sep; 143A(17):2029-34. PubMed ID: 17663480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study.
    Al-Kouatly HB; Makhamreh MM; Rice SM; Smith K; Harman C; Quinn A; Valcarcel BN; Firman B; Liu R; Hegde M; Critchlow E; Berger SI
    Genet Med; 2021 Jul; 23(7):1325-1333. PubMed ID: 33686258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disorders and pregnancy outcomes of non-immune hydrops fetalis in a tertiary referral center.
    Guo D; He S; Lin N; Dai Y; Li Y; Xu L; Wu X
    BMC Med Genomics; 2023 Apr; 16(1):83. PubMed ID: 37081464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema.
    Noelle V; Knuepfer M; Pulzer F; Schuster V; Siekmeyer W; Matthijs G; Vogtmann C
    Eur J Pediatr; 2005 Apr; 164(4):223-6. PubMed ID: 15645285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological presentation of a congenital disorder of glycosylation CDG-Ia: implications for diagnosis and genetic counseling.
    Drouin-Garraud V; Belgrand M; Grünewald S; Seta N; Dacher JN; Hénocq A; Matthijs G; Cormier-Daire V; Frébourg T; Saugier-Veber P
    Am J Med Genet; 2001 Jun; 101(1):46-9. PubMed ID: 11343337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.